Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Clinical trial NCT04888468 · COMPLETED
Trial details
- NCT number
- NCT04888468
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2021-06-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.